1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Stand Up To Cancer – Pediatric Neuro-Oncology Consortium (PNOC) and the PNOC Foundation Diffuse Midline Glioma (DMG) Discoveries Challenge Grant Program is sponsored by Stand Up To Cancer (SU2C), Pediatric Neuro-Oncology Consortium (PNOC), PNOC Foundation. This program supports highly innovative translational research that provides a step-change improvement in therapy for Diffuse Midline Glioma (DMG), including diffuse intrinsic pontine glioma (DIPG).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: No specific eligibility criteria provided in the search results, generally researchers focusing on pediatric neuro-oncology. Confirm the full requirements in the official notice before applying.
Stand Up To Cancer – Pediatric Neuro-Oncology Consortium (PNOC) and the PNOC Foundation Diffuse Midline Glioma (DMG) Discoveries Challenge Grant Program is funded by Stand Up To Cancer (SU2C), Pediatric Neuro-Oncology Consortium (PNOC), PNOC Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDC-RFA-EH-27-0074 posted as a forecast September 22, 2026: 6 expected awards at $750,000 to $900,000. That is flat funding against the expiring cycle — and the only proven way in is the consortium model Arizona used to bring three states under one award.
Read articlePMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read articleOn May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read article